Aesthetic Medicine Trends 2026: March Roundup for Certified Aesthetic Providers
March 2026 brought meaningful advances in aesthetic medicine, from new FDA-approved options for managing GLP-1-related facial volume loss to strengthening clinical evidence for polynucleotide and exosome therapies. This roundup covers the developments most relevant to certified aesthetic providers, including new consensus guidance, shifting patient demographics, and an evolving regulatory landscape.